GSK - グラクソ・スミスクライン ()


   Global Perinatal Infections Market Analysis By Size, Growth Rate, Share, Trends, Key Players, COVID-19 Impact 2020-2027||Arbor Pharmaceuticals, Par Pharmaceutical, Mylan N.V., GlaxoSmithKline Plc., Novartis AG  2020/10/10 15:56:06 OpenPR
“Global Perinatal Infections Market–Industry Trends and Forecast to 2027” New Research Report Added to database. The report width Of pages : 350 Figures: 60 And Tables: 220 in it.The global Perinatal Infections market is highly fragmented and the
   Global Asthma and COPD Smart Inhalers Markets Report 2020 with Profiles of AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Teva Pharma -  2020/10/09 09:39:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Smart Inhalers: Global Markets" report has been added to's offering. The current report offers a comprehensive picture of the smart inhalers market. Smart inhalers prescribed for the treatment of asthma and COPD are included in the scope of the study. The global market's growth is attributed to factors such as the growing prevalence of respiratory diseases, a rise in the world's geriatric population, growing collaboration between pharma and d
   GlaxoSmithKline: An Unusual Defensive Healthcare Play (NYSE:GSK)  2020/10/09 03:26:53 Seeking Alpha
GlaxoSmithKline is in one of its best positions in recent history, with strong financials, a very diversified business and potential for big upside.
   Pazopanib Market To Set Outstanding Growth In Key Regions By 2025 Featuring Renowned Key Players | GlaxoSmithKline, Novartis  2020/10/08 15:20:38 OpenPR
The Pazopanib market 2020 report analyses global acceptance of trends, future growth potential, key drivers, limitations, opportunities, and best practices that are taken place in market. The report also examines growth potential, market sizes and revenue forecasts (2020-2025)across different regions
   Human Rotavirus Vaccine Market Rapidly Growing in Healthcare Sector by 2020-2027 with Prominent Players: Merck & Co.Inc., Bharat Biotech, GlaxoSmithKline plc.  2020/10/08 13:23:04 OpenPR
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the
   GSK and Sanofi in 'advanced discussions' with EU over Covid-19 vaccine  2020/08/03 11:22:00 Evening Standard
Drugs giants GlaxoSmithKline and Sanofi today neared the completed a trio of key agreements to supply their Covid-19 vaccine, amid discussions with the EU. The pair said they are in “advanced discussions” with the European bloc to supply 300 million doses of their candidate, which uses Sanofi's recombinant protein-based technology combined with GSK's pandemic adjuvant system.
   GlaxoSmithKline PLC Total Voting Rights  2020/08/03 10:31:00 ADVFN UK
GlaxoSmithKline PLC 03 August 2020 GlaxoSmithKline plc Total Voting Rights and Capital In conformity with the Financial Conduct…
   GlaxoSmithKline und Sanofi beliefern EU mit COVID-19-Impfstoff - Aktien in Grün  2020/08/03 08:09:00 Finanzen CH
Wie das britische Pharmaunternehmen mitteilte, basiert der Impfstoffkandidat auf Sanofis Technologie zur Herstellung eines Grippeimpfstoffs sowie auf der Pandemie-Adjuvans-Technologie von GSK . Produziert würden die…
   Sanofi, GSK to supply 300M COVID-19 vaccine doses to EU (NASDAQ:SNY)  2020/08/03 07:38:16 Seeking Alpha
Sanofi (NASDAQ:SNY) and development partner GlaxoSmithKline (NYSE:GSK) are in advanced discussions with the European Union (EU) to supply up to 300M doses
   The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings  2020/08/02 15:08:50 Benzinga
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in, with big pharma tie-ups flaunting positive tidings. In the biggest ever coronavirus funding deal, the Sanofi SA (NASDAQ: SNY ) GlaxoSmithKline plc (NYSE: GSK ) won a joint $2.1 billion U.S. federal funding award. Here're the key catalysts for the unfolding week: Conferences 72nd National Hemophilia Foundation's Annual Bleeding Disorders Meeting 2020 (virtual meeting): Aug. 1-8 PDUFA Dates FDA is scheduled to rule on DBV TECHNOLOGIE/S' ADR (NASDAQ: DBVT ) Viaskin peanut allergy patch Wednesday. However, cancellation of the Adcom meeting scheduled May 15 has poured cold water on the prospects of an approval coming through. Trevena Inc (NASDAQ: TRVN ) has a tryst with the FDA Friday, with respect to the NDA for its pain drug oleceridine, which was once rejected by the agency on the premise of inadequacy of clinical data.